NexImmune’s AIM™ Technology Enables Novel Adoptive Immunotherapy Approach for Cancer Treatment

News   Mar 07, 2014

 
NexImmune’s AIM™ Technology Enables Novel Adoptive Immunotherapy Approach for Cancer Treatment
 
 
 

RELATED ARTICLES

New Microscope Captures Detailed 3-D Movies of Cells Deep Within Living Systems

News

Merging lattice light sheet microscopy with adaptive optics reveals the most detailed picture yet of subcellular dynamics in multicellular organisms.

READ MORE

How Environmental Pollutants and Genetics Work Together in Rheumatoid Arthritis

News

It is well known that individuals with a particular version of human leukocyte antigen have an increased risk for rheumatoid arthritis, but there has been growing interest in the role of environmental pollutants. In a new mouse study, researchers probed the relationship between the two.

READ MORE

The End of the Breathalyzer?

News

Engineers have developed a miniature, ultra-low power injectable biosensor that could be used for continuous, long-term alcohol monitoring. The chip is small enough to be implanted in the body just beneath the surface of the skin and is powered wirelessly by a wearable device, such as a smartwatch or patch.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE